New Drug Approved for Antibiotic-Resistant Lung Disease

MONDAY, Oct. 1, 2018 — Arikayce has been approved by the U.S. Food and Drug Administration to treat lung disease caused by Mycobacterium avium complex (MAC) bacteria among people who don’t respond to conventional therapies, the FDA said in a news…
Source: Topamax